Clinical Trials Sponsored by Optum, Carolyn Martin and Ami Buikema
Total 1 results
-
GlaxoSmithKlineOptum, Carolyn Martin and Ami BuikemaCompletedTetanus | Diphtheria | Acellular Pertussis
Sponsors and Collaborators
- Firstbeat Technologies Ltd.
- farzaneh hojjat
- The Danish Physiotherapy Foundation
- Shanghai Greenvalley Pharmaceutical Co., Ltd.
- Sana Rouis
- Metro North Hospital and Health Services
- Società Italiana di Chirurgia Endoscopica e nuove tecnologie (SICE)
- Collèges Régionaux de Médecine Générale- CRMG - 18600 SANCOINS
- GlaxoSmithKline
- IGEA
- Coalition Internationale Sida
- Zhuzhou Qianjin Pharmaceutical Co., Ltd., 801, Zhuzhou, China
- Carol Davila University of Medicine and Pharmacy
- Swim Across America Foundation
- Acerus Biopharma Inc.
- Atos IT Solutions and Services Iberia
- Sidney Kimmel Cancer Center at Thomas Jefferson University
- Pei-Yuan Lee, MD
- Hongguan biological pharmaceutical co.
- Dr. Vivek Aggarwal
- View Full List
Medical Conditions
- Stage IVB Mycosis Fungoides and Sezary Syndrome
- Discetomy
- Landing Error Scoring System (LESS)
- Leanness
- Steroids
- CHOP
- Femoral Head Collapse
- Colistin Resistance in Bacteria
- Chronic Non Healing Wound
- Sporadic Angiomyolipomas (AMLs)
- Recurrent Carcinoma of the Vulva
- Exploring Risk Assessment and Recovery From COVID-19 Infection in Hospitalised Patients
- Assessment of Skin Moisturization Factors
- Insulin-like Growth Factor I
- Osteoarthritis in the Hip, Knee and Hand
- Stage I Skin Melanoma
- Distal Subungual Onychomycosis
- Care Coordination in Primary Care
- Cardiovascular Risk Score
- Schizoaffective
- View Full List
Drug Interventions
- 5-FU
- ITF2357
- Insulin (Actrapid)
- [C-11]PiB-PET/MRI
- AUY922
- Citalopram
- Antiretroviral drugs
- SPARC1104 modified dose regimen III
- Ezabenlimab
- Paclitaxel (albumin-bound) combined with Oxaliplatin and S-1
- Medium dose of BIBT 986 CL, per i.v. infusion
- B=Inhaled Alprazolam 0.5 mg
- Doxophylline
- Rose Bengal
- TOCOSOL(R) Paclitaxel
- 0.9% Sodium Chloride Injection
- Standard treatment
- BH002
- R-metHuLeptin
- NDI-034858 study drug
- View Full List
CROs by country
- Contract Research Organizations in Angola
- Contract Research Organizations in Austria
- Contract Research Organizations in Bahrain
- Contract Research Organizations in Belgium
- Contract Research Organizations in China
- Contract Research Organizations in Georgia
- Contract Research Organizations in Italy
- Contract Research Organizations in Latvia
- Contract Research Organizations in Mali
- Contract Research Organizations in Malta
- Contract Research Organizations in Serbia
- Contract Research Organizations in Trinidad & Tobago
- Contract Research Organizations in Zimbabwe
- CRO list by country